Posted:
1/29/2026, 2:03:44 AM
Location(s):
Massachusetts, United States ⋅ Cambridge, Massachusetts, United States
Experience Level(s):
Senior
Field(s):
Medical, Clinical & Veterinary
About This Role:
Biogen is seeking a motivated and passionate individual to join our team as a Director, Pathology. This role is integral to our mission of delivering transformative and safe drugs to patients by providing veterinary toxicologic pathology expertise across our diverse portfolio. You will be responsible for supporting the advancement of our pipeline by designing, executing, and interpreting toxicology studies, assessing safety risks, and contributing to project strategy across all phases of Drug Discovery and Development, as well as for marketed products. As part of an established team within the Nonclinical Safety function, you will collaborate closely with Toxicology and Study Management functions. In this high-impact position, you will play a pivotal role in enabling the delivery of first-in-class treatments and therapies that improve patient outcomes.
What You’ll Do:
Provide pathology expertise to the design and conduct of GLP and non-GLP nonclinical safety studies to enable progression of discovery and development programs to decision points.
Conduct pathology peer reviews and provide expert evaluation of clinical and anatomic pathology data to inform study results and conclusions; conduct primary pathology evaluations as needed.
Review anatomic and clinical pathology reports; review integrated toxicology reports for finalization.
Serve as a contributing author to pathology sections of regulatory documents such as INDs, NDA/BLAs, IBs, and respond to Health Authority questions.
Contribute to and/or lead the communication of safety study results and conclusions to program teams and internal and external stakeholders.
Provide comparative medical perspective to drug development teams regarding the clinical relevance of findings from nonclinical safety assessment studies.
Contribute to initiatives aimed at improving the efficiency of pathology processes and procedures, including collaborative efforts with CRO partners.
Consult with colleagues on pathology-related results and investigate unexpected findings.
Participate in business development and due diligence evaluations for potential in-licensing, partnerships, and acquisitions of external assets.
Collaborate with colleagues on the design of investigative toxicology plans and studies.
Participate in or lead Nonclinical Safety cross-functional initiatives and special purpose subteams to address emerging trends or new approaches in toxicology and pathology.
Who You Are:
You are an experienced toxicologic pathologist with a robust track record of developing and executing nonclinical safety studies across all phases of drug development. You thrive on making data-informed decisions that enable safe and effective therapies to reach patients.
Required Skills:
DVM or equivalent; MS/PhD preferred or significant research experience in a relevant scientific discipline.
12+ years of veterinary anatomic pathology post-graduate experience in the biopharmaceutical or contract research industry.
Board certification in veterinary pathology (DACVP or equivalent) required.
Ability and experience as a toxicologic pathologist to support discovery and/or development programs.
Experience with multiple modalities, including oligonucleotides, small molecules, biologics, and antibody-drug conjugates.
Proven leadership, organizational, and time management skills, including the ability to collaboratively interact effectively with internal/external colleagues and experts for the review of anatomic pathology.
Must possess good communication and technical writing skills, capable of engaging in scientific dialogue among large groups of scientists, senior management, and external scientific experts.
Ability to express views and opinions, listen, and accept conflicting points of view.
#SM-1
Additional Information
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Website: https://www.biogen.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 5001-10000
Year Founded: 1978
IPO Status: Private
Industries: Biotechnology ⋅ Health Care ⋅ Life Science ⋅ Manufacturing ⋅ Medical ⋅ Precision Medicine ⋅ Therapeutics